Markets
Abrdn Life Sciences Investors (HQL)
HQLNYSEInvestment Managers
$18.50
+0.1600 (+0.87%) today
At the close, Nov 13, 4:00 PM ET. After hours $18.50 +1.37%
+0.87% 1D
- Market cap
- $468.65m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $17.88 to $18.48
- 52-week range
- $15.66 to $22.67
- Average volume
- –
- Previous close
- $18.34
Financials
No quarterly figures from the source.
News
8 latest- Notable Two Hundred Day Moving Average Cross - HQLBNK Invest · Nov 2, 2026
- This Top AI Trade for 2026 Pays a Huge 11.6% Dividend (It's Not a Tech Stock)BNK Invest · Feb 2, 2026
- These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a DiscountThe Motley Fool · Apr 30, 2025
- Insider Sale: 10% owner at $HQL Sells 36,536 SharesQuiver Quantitative · Feb 13, 2025
- Insider Sale: 10% owner at $HQL Sells 19,756 SharesQuiver Quantitative · Feb 12, 2025
- Insider Sale: 10% owner at $HQL Sells 1,846 SharesQuiver Quantitative · Feb 5, 2025
- Insider Sale: 10% owner at $HQL Sells 15,143 SharesQuiver Quantitative · Feb 3, 2025
- Insider Sale: 10% owner at $HQL Sells 11,674 SharesQuiver Quantitative · Jan 30, 2025
The company
Tekla Life Sciences Investors is a United States based closedend management investment company. Its investment objective is to seek longterm capital appreciation by investing primarily in the securities of life sciences companies.
- Sector
- Finance
- Industry
- Investment Managers
- Exchange
- NYSE
- Region
- North America
- Website
- abrdnhql.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.